{"id":"priorixtetra","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fever"},{"rate":"null","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The vaccine contains weakened forms of the measles, mumps, rubella, and varicella viruses, which trigger an immune response and provide immunity against these diseases. This immune response is mediated by the production of antibodies and the activation of immune cells, such as T-cells and B-cells.","oneSentence":"PriorixTetra is a live attenuated vaccine that stimulates the body's immune system to produce antibodies against measles, mumps, rubella, and varicella.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:53.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Measles, mumps, rubella, and varicella prevention in individuals 9 months of age and older"}]},"trialDetails":[{"nctId":"NCT01506193","phase":"PHASE3","title":"Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-02-06","conditions":"Rubella, Varicella, Measles","enrollment":716}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":19,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MMRV vaccine (GSK208136)"],"phase":"phase_3","status":"active","brandName":"PriorixTetra™","genericName":"PriorixTetra™","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"PriorixTetra is a live attenuated vaccine that stimulates the body's immune system to produce antibodies against measles, mumps, rubella, and varicella. Used for Measles, mumps, rubella, and varicella prevention in individuals 9 months of age and older.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}